GURNEY AUSTIN L.,SATO AARON KEN,BOND CHRISTOPHER JOHN
申请号:
NZ62372412
公开号:
NZ623724A
申请日:
2012.09.24
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
Disclosed is a bispecific antibody comprising: a) a first antigen-binding site that specifically binds human vascular endothelial growth factor (VEGF), and b) a second antigen-binding site that specifically binds human delta-like 4 ligand (DLL4), comprising the CDRs of the sequences as defined in the specification. Also disclosed is its use in treating cancer.